デフォルト表紙
市場調査レポート
商品コード
995259

幹細胞の市場動向・市場シェア・市場規模の予測 (2021-2028年):製品 (間葉系細胞・成体幹細胞・iPSC)・用途・技術 (細胞回収・凍結保存)・治療法・地域別

Stem Cells Market Size, Share & Trends Analysis Report By Product (Mesenchymal, Adult, iPSCs), By Application, By Technology (Cell Acquisition, Cryopreservation), By Therapy, By Region, And Segment Forecasts, 2021 - 2028

出版日: | 発行: Grand View Research, Inc. | ページ情報: 英文 150 Pages | 納期: 2-10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.65円
幹細胞の市場動向・市場シェア・市場規模の予測 (2021-2028年):製品 (間葉系細胞・成体幹細胞・iPSC)・用途・技術 (細胞回収・凍結保存)・治療法・地域別
出版日: 2021年02月23日
発行: Grand View Research, Inc.
ページ情報: 英文 150 Pages
納期: 2-10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の幹細胞の市場規模は予測期間中8.8%のCAGRで推移し、2028年には184億米ドルの規模に成長すると予測されています。

幹細胞バンクの増加、幹細胞治療への注目の高まり、再生医療開発に向けた広範な研究などの要因が同市場の成長を推進しています。

当レポートでは、世界の幹細胞の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、パイプライン分析、市場規模の推移・予測、タイプ・製品・技術・用途・治療法・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場可変因子・動向・展望

  • 市場動向・展望
  • 市場の見通し
  • 市場の分類・範囲
  • 定義
  • 市場力学
  • 普及・成長の見通しマッピング
  • パイプライン分析
  • SWOT分析
  • ポーターの分析
  • COVID-19:影響分析
  • 主要な取引・戦略的提携

第4章 市場予測・動向分析:製品別

  • 成体幹細胞(ASC)
    • 造血細胞
    • 間葉系細胞
    • 神経細胞
    • 上皮/皮膚細胞
    • その他
  • ヒト胚性幹細胞
  • 人工多能性幹細胞(iPSCs)
  • VSEL幹細胞

第5章 市場予測・動向分析:用途別

  • 再生医療
  • 創薬・開発

第6章 市場予測・動向分析:技術別

  • 細胞回収
  • 細胞生産
  • 凍結保存
  • 細胞増殖・培養

第7章 市場予測・動向分析:治療法別

  • 自家細胞
  • 同種異系細胞

第8章 市場予測・動向分析:地域・主要国別

  • 市場シェア実績・予測
  • 市場規模の推移・予測
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

  • 戦略的枠組み
  • 参入事業者の分類
  • 企業プロファイル
    • Advanced Cell Technology, Inc.
    • STEMCELL Technologies, Inc.
    • BioTime, Inc.
    • Cellular Engineering Technologies Inc.
    • CellGenix GmbH
    • PromoCell GmbH
    • Lonza
    • Kite Pharma
    • Cellartis AB
    • Angel Biotechnology
    • Brainstorm Cell Therapeutics
    • Celgene Corporation
    • Osiris Therapeutics, Inc.
    • Genea Biocells
    • Bioheart Inc.
    • Waisman Biomanufacturing
    • TiGenix
    • Caladrius
    • Gamida Cell.
    • Pluristem
図表

List of Tables

  • TABLE 1 North America stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 2 North America adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 3 North America stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 4 North America regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 5 North America stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 6 North America cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 7 North America stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 8 North America autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 9 U.S. stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 10 U.S. adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 11 U.S. stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 12 U.S. regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 13 U.S. stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 14 U.S. cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 15 U.S. stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 16 U.S. autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 17 Canada stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 18 Canada adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 19 Canada stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 20 Canada regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 21 Canada stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 22 Canada cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 23 Canada stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 24 Canada autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 25 Europe stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 26 Europe adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 27 Europe stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 28 Europe regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 29 Europe stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 30 Europe cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 31 Europe stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 32 Europe autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 33 Germany stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 34 Germany adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 35 Germany stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 36 Germany regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 37 Germany stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 38 Germany cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 39 Germany stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 40 Germany autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 41 U.K. stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 42 U.K. adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 43 U.K. stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 44 U.K. regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 45 U.K. stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 46 U.K. cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 47 U.K. stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 48 U.K. autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 49 France stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 50 France adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 51 France stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 52 France regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 53 France stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 54 France cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 55 France stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 56 France autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 57 Spain stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 58 Spain adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 59 Spain stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 60 Spain regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 61 Spain stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 62 Spain cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 63 Spain stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 64 Spain autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 65 Italy stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 66 Italy adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 67 Italy stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 68 Italy regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 69 Italy stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 70 Italy cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 71 Italy stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 72 Italy autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 73 Asia Pacific stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 74 Asia Pacific adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 75 Asia Pacific stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 76 Asia Pacific regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 77 Asia Pacific stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 78 Asia Pacific cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 79 Asia Pacific stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 80 Asia Pacific autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 81 Japan stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 82 Japan adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 83 Japan stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 84 Japan regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 85 Japan stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 86 Japan cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 87 Japan stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 88 Japan autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 89 China stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 90 China adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 91 China stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 92 China regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 93 China stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 94 China cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 95 China stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 96 China autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 97 India stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 98 India adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 99 India stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 100 India regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 101 India stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 102 India cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 103 India stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 104 India autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 105 Latin America stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 106 Latin America adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 107 Latin America stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 108 Latin America regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 109 Latin America stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 110 Latin America cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 111 Latin America stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 112 Latin America autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 113 Brazil stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 114 Brazil adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 115 Brazil stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 116 Brazil regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 117 Brazil stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 118 Brazil cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 119 Brazil stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 120 Brazil autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 121 Mexico stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 122 Mexico adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 123 Mexico stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 124 Mexico regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 125 Mexico stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 126 Mexico cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 127 Mexico stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 128 Mexico autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 129 Middle East & Africa stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 130 Middle East & Africa adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 131 Middle East & Africa stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 132 Middle East & Africa regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 133 Middle East & Africa stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 134 Middle East & Africa cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 135 Middle East & Africa stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 136 Middle East & Africa autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 137 South Africa stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 138 South Africa adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 139 South Africa stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 140 South Africa regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 141 South Africa stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 142 South Africa cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 143 South Africa stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 144 South Africa autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 145 Saudi Arabia stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 146 Saudi Arabia adult stem cells market estimates & forecasts, by product, 2017 - 2028 (USD Million)
  • TABLE 147 Saudi Arabia stem cells market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 148 Saudi Arabia regenerative medicine market estimates & forecasts, by application, 2017 - 2028 (USD Million)
  • TABLE 149 Saudi Arabia stem cells market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 150 Saudi Arabia cell acquisition technology market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
  • TABLE 151 Saudi Arabia stem cells market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)
  • TABLE 152 Saudi Arabia autologous stem cell therapy market estimates & forecasts, by therapy, 2017 - 2028 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information Procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing & forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Market summary
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation & scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Market restraint relevance analysis (Current & future impact)
  • FIG. 12 Penetration & growth prospect mapping for application, 2020
  • FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 14 Porter's Five Forces Analysis
  • FIG. 15 Global stem cells market: Product outlook key takeaways
  • FIG. 16 Global stem cells market: Product movement analysis
  • FIG. 17 Global adult stem cells market, 2017 - 2028 (USD Million)
  • FIG. 18 Global hematopoietic stem cells (blood stem cells) market, 2017 - 2028 (USD Million)
  • FIG. 19 Global mesenchymal stem cells market, 2017 - 2028 (USD Million)
  • FIG. 20 Global neural stem cells market, 2017 - 2028 (USD Million)
  • FIG. 21 Global epithelial/skin stem cells market, 2017 - 2028 (USD Million)
  • FIG. 22 Global other adult stem cells market, 2017 - 2028 (USD Million)
  • FIG. 23 Global human embryonic stem cells market, 2017 - 2028 (USD Million)
  • FIG. 24 Global induced pluripotent stem cells market, 2017 - 2028 (USD Million)
  • FIG. 25 Global very small embryonic-like stem cells market, 2017 - 2028 (USD Million)
  • FIG. 26 Global stem cells market: Application outlook key takeaways
  • FIG. 27 Global stem cells market: Application movement analysis
  • FIG. 28 Global regenerative medicine market, 2017 - 2028 (USD Million)
  • FIG. 29 Global neurology market, 2017 - 2028 (USD Million)
  • FIG. 30 Global orthopedics market, 2017 - 2028 (USD Million)
  • FIG. 31 Global oncology market, 2017 - 2028 (USD Million)
  • FIG. 32 Global hematology market, 2017 - 2028 (USD Million)
  • FIG. 33 Global cardiovascular and myocardial infraction market, 2017 - 2028 (USD Million)
  • FIG. 34 Global injuries market, 2017 - 2028 (USD Million)
  • FIG. 35 Global diabetes market, 2017 - 2028 (USD Million)
  • FIG. 36 Global liver disorder market, 2017 - 2028 (USD Million)
  • FIG. 37 Global incontinence market, 2017 - 2028 (USD Million)
  • FIG. 38 Global drug discovery and development market, 2017 - 2028 (USD Million)
  • FIG. 39 Global Stem cells market: Technology outlook key takeaways
  • FIG. 40 Global Stem cells market: Technology movement analysis
  • FIG. 41 Global cell acquisition market, 2017 - 2028 (USD Million)
  • FIG. 42 Global bone marrow harvest market, 2017 - 2028 (USD Million)
  • FIG. 43 Global umbilical blood cord market, 2017 - 2028 (USD Million)
  • FIG. 44 Global apheresis market, 2017 - 2028 (USD Million)
  • FIG. 45 Global cell production market, 2017 - 2028 (USD Million)
  • FIG. 46 Global therapeutic cloning market, 2017 - 2028 (USD Million)
  • FIG. 47 Global in vitro fertilization market, 2017 - 2028 (USD Million)
  • FIG. 48 Global cell culture market, 2017 - 2028 (USD Million)
  • FIG. 49 Global isolation market, 2017 - 2028 (USD Million)
  • FIG. 50 Global cryopreservation market, 2017 - 2028 (USD Million)
  • FIG. 51 Global expansion and sub-culture market, 2017 - 2028 (USD Million)
  • FIG. 52 Global Stem cells market: Therapy outlook key takeaways
  • FIG. 53 Global Stem cells market: Therapy movement analysis
  • FIG. 54 Global autologous market, 2017 - 2028 (USD Million)
  • FIG. 55 Global allogenic market, 2017 - 2028 (USD Million)
  • FIG. 56 Regional market place: Key takeaway
  • FIG. 57 Stem cells regional outlook, 2020 & 2028
  • FIG. 58 North America stem cells market, 2017 - 2028 (USD Million)
  • FIG. 59 U.S stem cells market, 2017 - 2028 (USD Million)
  • FIG. 60 Canada stem cells market, 2017 - 2028 (USD Million)
  • FIG. 61 Europe stem cells market, 2017 - 2028 (USD Million)
  • FIG. 62 Germany stem cells market, 2017 - 2028 (USD Million)
  • FIG. 63 U.K. stem cells market, 2017 - 2028 (USD Million)
  • FIG. 64 France stem cells market, 2017 - 2028 (USD Million)
  • FIG. 65 Spain stem cells market, 2017 - 2028 (USD Million)
  • FIG. 66 Italy stem cells market, 2017 - 2028 (USD Million)
  • FIG. 67 Asia Pacific stem cells market, 2017 - 2028 (USD Million)
  • FIG. 68 Japan stem cells market, 2017 - 2028 (USD Million)
  • FIG. 69 China stem cells market, 2017 - 2028 (USD Million)
  • FIG. 70 India stem cells market, 2017 - 2028 (USD Million)
  • FIG. 71 Latin America stem cells market, 2017 - 2028 (USD Million)
  • FIG. 72 Brazil stem cells market, 2017 - 2028 (USD Million)
  • FIG. 73 Mexico stem cells market, 2017 - 2028 (USD Million)
  • FIG. 74 Middle East & Africa stem cells market, 2017 - 2028 (USD Million)
  • FIG. 75 South Africa stem cells market, 2017 - 2028 (USD Million)
  • FIG. 76 Saudi Arabia stem cells market, 2017 - 2028 (USD Million)
  • FIG. 77 Strategy framework
  • FIG. 78 Participant categorization 
目次
Product Code: 978-1-68038-130-6

Stem Cells Market Growth & Trends

The global stem cells market size is expected to reach USD 18.4 billion by 2028, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 8.8% during the forecast period. The market is driven by the rising number of stem cell banks, growing focus on increasing therapeutic potential of these, and extensive research for the development of regenerative medicines, among other factors.

Companies are receiving robust funding for the development of cellular therapies for cancer, which is anticipated to supplement the market growth. For instance, in February 2021, Notch Therapeutics, Inc. received funding of USD 85 million for developing induced pluripotent therapies for cancer. The investment will support the development of the company's iPSC-derived T cell-based therapeutic candidates and expanding the application of their proprietary Engineered Thymic Niche (ETN) platform.

The increasing focus on regenerative medicines is further driving the market growth. The iPSCs are gaining popularity for the development of personalized cellular therapies and are creating new opportunities for regenerative medicine. For instance, in September 2020, researchers from Duke-NUS and Monash University discovered the first stem cell that can help in the treatment of placenta complications during pregnancy.

The researchers discovered a new way for creating induced trophoblast stem cells which can be used for making placenta cells. The discovery will facilitate in developing a model human placenta in vitro and enabling a pathway for future cell therapies. The administration of cell therapy demonstrated positive results in the treatment of COVID-19 patients, which is further contributing to the market growth. In January 2020, a group of researchers used stem cell treatment on patients in Beijing, China for checking its effectiveness against COVID-19.

The patients received a single infusion of mesenchymal stem cells (MSCs) which was found to be effective in developing an immune response. However, to date, there are no MSCs that are approved by the U.S. Food and Drug Administration (FDA) for the treatment of COVID-19 owing to insufficient data on their role in treating COVID-19.

Stem Cells Market Report Highlights

ASCs segment accounted for the largest share of 85.7% in 2020 as it is considered as a gold standard in stem cell-based therapies. They are widely accepted owing to their consistent clinical success especially in hematopoietic transplants and there is a relatively less controversial view regarding their origin

The iPSC segment is expected to witness a lucrative CAGR of 9.3% through 2021-2028 owing to the increasing focus of companies in using iPS for cell therapies. For instance, in July 2020, Cynata Therapeutics Limited announced positive results for the phase 1 clinical trial of CYP-001, the company's lead induced pluripotent stem cell (iPSC)-derived Cymerus

Regenerative medicine dominated with a market share of 89.1% in 2020 owing to increasing funding by the government for the development of regenerative medicines. For instance, in October 2020, the AusBiotech-led consortium received funding of $300,000 from MTPConnect's Industry Growth Centre Project Fund for the development of regenerative medicines in the country

Cell acquisition held the largest market share of 35.8% in 2020 and is expected to expand at the fastest CAGR through 2021-2028 owing to increasing research studies involving cell harvesting

Allogenic therapy dominated with a market share of 58.2% in 2020 owing to the increasing application of allogeneic stem cell transplants for cancer treatment

The North America market encompasses U.S. and Canada. The factors contributing to the market growth in the region include robust government funding, increasing research, and the presence of prominent players.

Asia Pacific is expected to expand with the fastest CAGR of 9.0% through 2021 to 2028 owing to increasing expansion by key companies in this region. For instance, in April 2020, Seneca Biopharma completed its new stem cell manufacturing facility in Suzhou, China

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Information Procurement
  • 1.2 Data Analysis

Chapter 2 Executive Summary

Chapter 3 Industry Outlook, Trends & Scope

  • 3.1 Market Trends & Outlook
  • 3.2 Market Lineage Outlook
  • 3.3 Market Segmentation & Scope
  • 3.4 Definitions
  • 3.5 Market Dynamics
      • 3.5.1market Driver Analysis
      • 3.5.1.1 ongoing Developments In Regenerative Medicine
      • 3.5.1.2 rising Funds For Accelerating Stem Cell Research
      • 3.5.1.3 growing Demand For Stem Cell Banking
      • 3.5.1.4 increasing Prevalence Of Genetic Disorders
    • 3.5.2 market Restraint Analysis
      • 3.5.2.1 Ethical concern related to stem cell research
      • 3.5.2.2 Lack of a well-defined regulatory framework in certain applications of stem cell
  • 3.6 Penetration & Growth Prospect Mapping for Application, 2020
  • 3.7 Pipeline Analysis, 2020
  • 3.8 Stem Cells -SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
  • 3.9 Industry Analysis - Porter's
  • 3.10 COVID-19 Impact Analysis
    • 3.10.1 challenge Analysis
    • 3.10.2 opportunities Analysis
    • 3.10.3 key Development & Market Initiatives
  • 3.11 Major Deals & Strategic Alliances

Chapter 4 Stem Cells Market Categorization: Product Estimates & Trend Analysis

  • 4.1 Global Stem Cells Market: Product Movement Analysis
  • 4.2 Adult Stem Cells (ASCs)
    • 4.2.1 global Adult Stem Cells Market, 2017 - 2028 (USD Million)
    • 4.2.2 Hematopoietic
      • 4.2.2.1 global Hematopoietic Stem Cells (Blood Stem Cells) Market, 2017 - 2028 (USD Million)
    • 4.2.3 Mesenchymal
      • 4.2.3.1 global Mesenchymal Stem Cells Market, 2017 - 2028 (USD Million)
    • 4.2.4 Neural
      • 4.2.4.1 global Neural Stem Cells Market, 2017 - 2028 (USD Million)
    • 4.2.5 Epithelial/Skin
      • 4.2.5.1 global Epithelial/Skin Stem Cells Market, 2017 - 2028 (USD Million)
    • 4.2.6 Others
      • 4.2.6.1 global Other Adult Stem Cells Market, 2017 - 2028 (USD Million)
  • 4.3 Human Embryonic Stem Cells
    • 4.3.1 global Human Embryonic Stem Cells Market, 2017 - 2028 (USD Million)
  • 4.4 Induced Pluripotent Stem Cells (Ipscs)
    • 4.4.1 global Induced Pluripotent Stem Cells Market, 2017 - 2028 (USD Million)
  • 4.5 Very Small Embryonic Like Stem Cells
    • 4.5.1 global Very Small Embryonic Like Stem Cells Market, 2017 - 2028 (USD Million)

Chapter 5 Stem Cells Market Categorization: Application Estimates & Trend Analysis

  • 5.1 Global Stem Cells Market: Application Movement Analysis
  • 5.2 Regenerative Medicine
    • 5.2.1 global Regenerative Medicine Market, 2017 - 2028 (USD Million)
      • 5.2.2neurology
      • 5.2.2.1 global Neurology Market, 2017 - 2028 (USD Million)
      • 5.2.3orthopedics
      • 5.2.3.1 global Orthopedics Market, 2017 - 2028 (USD Million)
      • 5.2.4oncology
      • 5.2.4.1 global Oncology Market, 2017 - 2028 (USD Million)
      • 5.2.5hematology
      • 5.2.5.1 global Hematology Market, 2017 - 2028 (USD Million)
      • 5.2.6cardiovascular And Myocardial Infraction
      • 5.2.6.1 global Cardiovascular And Myocardial Infraction Market, 2017 - 2028 (USD Million)
      • 5.2.7injuries
      • 5.2.7.1 global Injuries Market, 2017 - 2028 (USD Million)
      • 5.2.8diabetes
      • 5.2.8.1 global Diabetes Market, 2017 - 2028 (USD Million)
      • 5.2.9liver Disorder
      • 5.2.9.1 global Liver Disorder Market, 2017 - 2028 (USD Million)
      • 5.2.10incontinence
      • 5.2.10.1 global Incontinence Market, 2017 - 2028 (USD Million)
      • 5.2.11others
  • 5.3 Drug Discovery And Development
    • 5.3.1 global Drug Discovery And Development Market, 2017 - 2028 (USD Million)

Chapter 6 Stem Cells Market Categorization: Technology Estimates & Trend Analysis

  • 6.1 Global Stem Cells Market: Technology Movement Analysis
  • 6.2 Cell Acquisition
    • 6.2.1 global Cell Acquisition Market, 2017 - 2028 (USD Million)
    • 6.2.2 bone Marrow Harvest
      • 6.2.2.1 global Bone Marrow Harvest Market, 2017 - 2028 (USD Million)
      • 6.2.3umbilical Blood Cord
      • 6.2.3.1 global Umbilical Blood Cord Market, 2017 - 2028 (USD Million)
      • 6.2.4apheresis
      • 6.2.4.1 global Apheresis Market, 2017 - 2028 (USD Million)
  • 6.3 Cell Production
    • 6.3.1 global Cell Production Market, 2017 - 2028 (USD Million)
      • 6.3.2therapeutic Cloning
      • 6.3.2.1 global Therapeutic Cloning Market, 2017 - 2028 (USD Million)
      • 6.3.3in Vitro Fertilization
      • 6.3.3.1 global In Vitro Fertilization Market, 2017 - 2028 (USD Million)
      • 6.3.4cell Culture
      • 6.3.4.1 global Cell Culture Market, 2017 - 2028 (USD Million)
      • 6.3.5isolation
      • 6.3.5.1 global Isolation Market, 2017 - 2028 (USD Million)
  • 6.4 Cryopreservation
    • 6.4.1 global Cryopreservation Market, 2017 - 2028 (USD Million)
  • 6.5 Expansion And Sub-Culture
    • 6.5.1 global Expansion And Sub-Culture Market, 2017 - 2028 (USD Million)

Chapter 7 Stem Cells Market Categorization: Therapy Estimates & Trend Analysis

  • 7.1 Global Stem Cells Market: Therapy Movement Analysis
  • 7.2 Autologous
    • 7.2.1 global Autologous Market, 2017 - 2028 (USD Million)
  • 7.3 Allogenic
    • 7.3.1 global Allogenic Market, 2017 - 2028 (USD Million)

Chapter 8 Stem Cells Market Categorization: Regional Estimates & Trend Analysis, by Product, Application, Technology, And Therapy

  • 8.1 Stem Cells Market Share by Region, 2020 & 2028
  • 8.2 North America
    • 8.2.1 North America Stem Cells Market, 2017 - 2028 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.2.2.2 U.S. stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.2.2.3 U.S. stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.2.2.4 U.S. stem cells market, by therapy, 2017 - 2028 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.2.3.2 Canada stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.2.3.3 Canada stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.2.3.4 Canada stem cells market, by therapy, 2017 - 2028 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Stem Cells Market, 2017 - 2028 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Germany stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.3.2.2 Germany stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.3.2.3 Germany stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.3.2.4 Germany stem cells market, by therapy, 2017 - 2028 (USD Million)
    • 8.3.3 U.K.
      • 8.3.3.1 U.K. stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.3.3.2 U.K. stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.3.3.3 U.K. stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.3.3.4 U.K. stem cells market, by therapy, 2017 - 2028 (USD Million)
    • 8.3.4 France
      • 8.3.4.1 France stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.3.4.2 France stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.3.4.3 France stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.3.4.4 France stem cells market, by therapy, 2017 - 2028 (USD Million)
      • 8.3.5Spain
      • 8.3.5.1 Spain stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.3.5.2 Spain stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.3.5.3 Spain stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.3.5.4 Spain stem cells market, by therapy, 2017 - 2028 (USD Million)
    • 8.3.6 Italy
      • 8.3.6.1 Italy stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.3.6.2 Italy stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.3.6.3 Italy stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.3.6.4 Italy stem cells market, by therapy, 2017 - 2028 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific Stem Cells Market, 2017 - 2028 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.4.2.2 Japan stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.4.2.3 Japan stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.4.2.4 Japan stem cells market, by therapy, 2017 - 2028 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.4.3.2 China stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.4.3.3 China stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.4.3.4 China stem cells market, by therapy, 2017 - 2028 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.4.4.2 India stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.4.4.3 India stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.4.4.4 India stem cells market, by therapy, 2017 - 2028 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Stem Cells Market, 2017 - 2028 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.5.2.2 Brazil stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.5.2.3 Brazil stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.5.2.4 Brazil stem cells market, by therapy, 2017 - 2028 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.5.3.2 Mexico stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.5.3.3 Mexico stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.5.3.4 Mexico stem cells market, by therapy, 2017 - 2028 (USD Million)
  • 8.6 Middle East & Africa (MEA)
    • 8.6.1 Middle East & Africa Stem Cells Market, 2017 - 2028 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.6.2.2 South Africa stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.6.2.3 South Africa stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.6.2.4 South Africa stem cells market, by therapy, 2017 - 2028 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia stem cells market, by product, 2017 - 2028 (USD Million)
      • 8.6.3.2 Saudi Arabia stem cells market, by application, 2017 - 2028 (USD Million)
      • 8.6.3.3 Saudi Arabia stem cells market, by technology, 2017 - 2028 (USD Million)
      • 8.6.3.4 Saudi Arabia stem cells market, by therapy, 2017 - 2028 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Strategy Framework
  • 9.2 Market Participation Categorization
  • 9.3 Company Profiles
    • 9.3.1 Advanced Cell Technology, Inc.
      • 9.3.1.1 Company overview
      • 9.3.1.2 Financial performance
      • 9.3.1.3 Product benchmarking
      • 9.3.1.4 Strategic Initiatives
    • 9.3.2 STEMCELL Technologies, Inc.
      • 9.3.2.1 Company overview
      • 9.3.2.2 Financial performance
      • 9.3.2.3 Product Benchmarking
      • 9.3.2.4 Strategic Initiatives
    • 9.3.3 BioTime, Inc.
      • 9.3.3.1 Company overview
      • 9.3.3.2 Cell Cure Neurosciences LTD.
      • 9.3.3.3 ESI BIO
      • 9.3.3.4 Financial performance
      • 9.3.3.5 Product Benchmarking
      • 9.3.3.6 Strategic Initiatives
    • 9.3.4 Cellular Engineering Technologies Inc.
      • 9.3.4.1 Company overview
      • 9.3.4.2 Financial performance
      • 9.3.4.3 Product benchmarking
      • 9.3.4.4 Strategic initiatives
    • 9.3.5 CellGenix GmbH
      • 9.3.5.1 Company overview
      • 9.3.5.2 Financial performance
      • 9.3.5.3 Product benchmarking
      • 9.3.5.4 Strategic initiatives
    • 9.3.6 PromoCell GmbH
      • 9.3.6.1 Company overview
      • 9.3.6.2 Financial performance
      • 9.3.6.3 Product benchmarking
      • 9.3.6.4 Strategic initiatives
    • 9.3.7 Lonza
      • 9.3.7.1 Company overview
      • 9.3.7.2 Financial performance
      • 9.3.7.3 Product benchmarking
      • 9.3.7.4 Strategic initiatives
    • 9.3.8 Kite Pharma
      • 9.3.8.1 Company overview
      • 9.3.8.2 Financial performance
      • 9.3.8.3 Product benchmarking
      • 9.3.8.4 Strategic initiatives
    • 9.3.9 Cellartis AB
      • 9.3.9.1 Company overview
      • 9.3.9.2 Financial performance
      • 9.3.9.3 Product benchmarking
      • 9.3.9.4 Strategic initiatives
    • 9.3.10 Angel Biotechnology
      • 9.3.10.1 Company overview
      • 9.3.10.2 Financial performance
      • 9.3.10.3 Product benchmarking
      • 9.3.10.4 Strategic initiatives
    • 9.3.11 Brainstorm Cell Therapeutics
      • 9.3.11.1 Company overview
      • 9.3.11.2 Financial performance
      • 9.3.11.3 Product benchmarking
      • 9.3.11.4 Strategic initiatives
    • 9.3.12 Celgene Corporation
      • 9.3.12.1 Company overview
      • 9.3.12.2 Financial performance
      • 9.3.12.3 Product benchmarking
      • 9.3.12.4 Strategic initiatives
    • 9.3.13 Osiris Therapeutics, Inc.
      • 9.3.13.1 Company overview
      • 9.3.13.2 Financial performance
      • 9.3.13.3 Product benchmarking
      • 9.3.13.4 Strategic initiatives
    • 9.3.14 Genea Biocells
      • 9.3.14.1 Company overview
      • 9.3.14.2 Financial performance
      • 9.3.14.3 Product benchmarking
      • 9.3.14.4 Strategic initiatives
    • 9.3.15 Bioheart Inc.
      • 9.3.15.1 Company overview
      • 9.3.15.2 Financial performance
      • 9.3.15.3 Product benchmarking
      • 9.3.15.4 Strategic initiatives
    • 9.3.16 Waisman Biomanufacturing
      • 9.3.16.1 Company overview
      • 9.3.16.2 Financial performance
      • 9.3.16.3 Product benchmarking
      • 9.3.16.4 Strategic initiatives
    • 9.3.17 TiGenix
      • 9.3.17.1 Company overview
      • 9.3.17.2 Financial performance
      • 9.3.17.3 Product benchmarking
      • 9.3.17.4 Strategic initiatives
    • 9.3.18 Caladrius
      • 9.3.18.1 Company overview
      • 9.3.18.2 Financial performance
      • 9.3.18.3 Product benchmarking
      • 9.3.18.4 Strategic initiatives
    • 9.3.19 Gamida Cell.
      • 9.3.19.1 Company overview
      • 9.3.19.2 Financial performance
      • 9.3.19.3 Product benchmarking
      • 9.3.19.4 Strategic initiatives
    • 9.3.20 Pluristem
      • 9.3.20.1 Company overview
      • 9.3.20.2 Financial performance
      • 9.3.20.3 Product benchmarking
      • 9.3.20.4 Strategic initiatives